EHRA Premium Access

Healthcare utilization and outcomes in atrial fibrillation patients treated by drug therapy versus a catheter ablation strategy

Congress Presentation

About the speaker

Associate Professor Martin Martinek

Ordensklinikum Linz Elisabethinen, Linz (Austria)
6 presentations
0 follower

9 more presentations in this session

Disagreement of ESC guidelines from 2016 and 2021 and HFA-PEFF and H2 FPEF scores in diagnosis of heart failure with preserved ejection fraction in atrial fibrillation patients

Speaker: Mrs S. Hubers (Maastricht, NL)


The role of biomarkers, sleep apnea and echocardiography as predictors of atrial fibrillation in a pacemaker population.

Speaker: Doctor A. Santos Sanchez (Burgos, ES)


Arrhythmic substrate in pulmonary vein isolation reprocedures in the era of the close protocol.

Speaker: Doctor C. Gonzalez De La Portilla-Concha (Seville, ES)


Minimizing radiation in cryoballon-based ablation of the pulmonary veins through a novel high-resolution wide-band dielectric imaging system

Speaker: Doctor V. Buia (Fuerth, DE)


Heterogeneity in voltage and activation time in the left atrium of atrial fibrillation patients undergoing pulmonary vein isolation

Speaker: Ms I. Meijer (Amsterdam, NL)


Access the full session

ePoster session 40

Speakers: Associate Professor M. Martinek, Mrs S. Hubers, Doctor A. Santos Sanchez, Doctor C. Gonzalez De La Portilla-Concha, Doctor V. Buia...

About the event


EHRA 2023

16 April - 18 April 2023

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb